Lv35
256 积分 2024-06-05 加入
In vivo engineered quadrivalent CAR-macrophages break tumor barrier,remodel TME and overcome tumor heterogeneity through antigen spreading
1个月前
已完结
Abstract 1321: In vivo immune cell programming using mRNA-LNP chimeric antigen receptors
1个月前
已关闭
Synergically enhanced anti-tumor immunity of in vivo panCAR by circRNA vaccine boosting
1个月前
已完结
Critical Considerations of mRNA-LNPs Technology for CAR-T Therapy: Components, Payloads and Emerging Horizons
1个月前
已完结
Peptide codes for organ-selective mRNA delivery
1个月前
已完结
Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering
1个月前
已完结
Polymer- and lipid-based gene delivery technology for CAR T cell therapy
1个月前
已完结
Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment
1个月前
已完结
Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye
2个月前
已完结
A potent bioreducible ionizable lipid nanoparticle enables siRNA delivery for retinal neovascularization inhibition
2个月前
已完结
皖公网安备34019202002308
